Notifications
Clear all
Anything about Research Chemicals
1
Posts
1
Users
0
Reactions
297
Views
Topic starter
30/01/2023 7:56 pm
Pharmacologically, PCP is a noncompetitive NMDA (N-methyl-D-aspartate) receptor antagonist and glutamate receptor antagonist, but also interacts with other receptor sites, and may have effects with dopamine, opioid and nicotinic receptors.